Kristin Stafford - 09 May 2023 Form 4/A - Amendment Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
Steven Robbins, as attorney in fact for Stafford, Kristin
Issuer symbol
NVCR
Transactions as of
09 May 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
17 May 2023, 16:58:35 UTC
Date Of Original Report
11 May 2023
Previous filing
31 Mar 2023
Next filing
06 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Stock Option (Right to Buy) Award $0 +15,873 $0.000000 15,873 09 May 2023 Ordinary Shares 15,873 $70.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Incorrectly listed in the original filing. This is the correct amount.
F2 These stock options will vest in equal parts on the first, second and third anniversary of the grant date.

Remarks:

Amendment corrects exercise price from the original filing. All other information is unchanged.